| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/25/2012 | CN102333540A Compositions and methods related to bacterial eap, emp, and/or adsa proteins |
| 01/25/2012 | CN102333539A Recombinant avian-infectious coryza vaccine and method for producing same |
| 01/25/2012 | CN102333538A Immunostimulatory oligonucleotides |
| 01/25/2012 | CN102333447A Compositions and methods for the treatment and prevention of lens fibrotic diseases |
| 01/25/2012 | CN102329809A Reverse genetic operating system of canine distemper virus (CDV)/R-20/8 vaccine strain and application thereof |
| 01/25/2012 | CN102329784A Japanese encephalitis virus like particles as well as preparation method and application thereof |
| 01/25/2012 | CN102329782A Avian flavivirus isolation strain and application thereof in preparation of vaccine |
| 01/25/2012 | CN102329781A Anti-human LIGHT monoclonal antibody and application thereof |
| 01/25/2012 | CN102329780A Anti-mycoplasma ST (swine testis) cell, and methods for culturing hog cholera virus low virulent strain and preparing hog cholera attenuated vaccine using same |
| 01/25/2012 | CN102329746A Porcine streptococcus disease and haemophilus parasuis disease combined inactivate vaccine and preparation method thereof |
| 01/25/2012 | CN102329394A Recombinant humanized anti-CD20 monoclonal antibody |
| 01/25/2012 | CN102329393A Monoclonal antibody resisting Abeta (beta-amyloid) 42 peptide and application thereof |
| 01/25/2012 | CN102329392A Specific anti-drug-resistant candida albicans hen egg yolk antibody IgY and preparation method and use thereof |
| 01/25/2012 | CN102327623A Preparation method of DNA (deoxyribonucleic acid) vaccine nanoparticles containing PLGA (Poly-lactide-co-glycolide) for ND (necastle disease) |
| 01/25/2012 | CN102327612A Steady humanized monoclonal antibody preparation |
| 01/25/2012 | CN102327611A Vaccine taking HBeAg egg white and/or HBeAg epitope polypeptide as immunogen |
| 01/25/2012 | CN102327610A Method by utilizing rabbit-origin cells to produce swine fever live vaccine |
| 01/25/2012 | CN102327609A Production method of encephalitis B vaccine |
| 01/25/2012 | CN102327608A Purifying method of encephalitis B vaccine |
| 01/25/2012 | CN102327607A Production method of encephalitis B vaccine preparation |
| 01/25/2012 | CN102327606A Brucella live vaccine and production method thereof |
| 01/25/2012 | CN102327605A Preparation process of meningococcal polysaccharide vaccine |
| 01/25/2012 | CN102327604A Construction and application of TRAIL (Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand) recombinant bacille calmette guerin (rBCG) |
| 01/25/2012 | CN102327603A Preparation method and use method of loach aeromonas sobria vaccine |
| 01/25/2012 | CN102327228A Preparation method of chitosan newcastle disease vaccine nanoparticles |
| 01/25/2012 | CN102180952B Foot and mouth disease virus antigen polypeptide, fusion antigen polypeptide and vaccine |
| 01/25/2012 | CN101822842B Reformation of high-pathogenicity avian influenza virus H5N1-HA gene and recombinant adeno-associated virus vaccine thereof |
| 01/25/2012 | CN101780272B Application of autovaccine preparation containing TGF beta 1 |
| 01/25/2012 | CN101658668B Method and application for preparing bacteria simulacrum by using antibacterial peptide |
| 01/25/2012 | CN101557824B Method for production of live smallpox vaccine |
| 01/25/2012 | CN101450209B Preparation method of transdermal immune influenza multivalent vaccine |
| 01/25/2012 | CN101406697B Preparation method of bacillus pyocyaneus vaccine |
| 01/25/2012 | CN101402687B Fusion protein with high immunogenicity and uses thereof |
| 01/25/2012 | CN101380467B Multi-connection inactivated vaccine (antigen) liquid concentration technique |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101739 Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector |
| 01/24/2012 | US8101727 Compositions and methods of use for antibodies of c-Met |
| 01/24/2012 | US8101726 Ligands binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) that inhibit downstream uPAR interactions: identification and use in diagnosis or therapy |
| 01/24/2012 | US8101725 Monoclonal antibodies to basic fibroblast growth factor |
| 01/24/2012 | US8101724 High-affinity human antibodies to human protease-activated receptor-2 |
| 01/24/2012 | US8101723 Monoclonal antibodies to fibroblast growth factor receptor 2 |
| 01/24/2012 | US8101721 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101381 Human cytokine receptor |
| 01/24/2012 | US8101372 Diagnosis and therapy of cancer using SGP28-related molecules |
| 01/24/2012 | US8101367 Antibodies specific to antigens of Bartonella henselae and use of these antigens in immunoassays |
| 01/24/2012 | US8101363 Obtaining a level of a marker of systemic inflammation in individual, comparing level of marker to a predetermined value specific for diagnosis of diabetes or diabetic complications, and characterizing the individual's risk profile |
| 01/24/2012 | US8101347 Method and compositions for immunization with the Pseudomonas V antigen |
| 01/24/2012 | US8101195 Artificial lymph node for treating cancer |
| 01/24/2012 | US8101194 Immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/24/2012 | US8101193 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 01/24/2012 | US8101192 Methods for producing an immune response to tuberculosis |
| 01/24/2012 | US8101191 Mycobacterial SecA2 mutants |
| 01/24/2012 | US8101190 Method for diagnosing staphylococcal infections |
| 01/24/2012 | US8101188 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/24/2012 | US8101187 Secreted Streptococcus pneumoniae proteins |
| 01/24/2012 | US8101186 Peptides that block the binding of IgG to FcRn |
| 01/24/2012 | US8101185 Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation |
| 01/24/2012 | US8101184 Treatment methods using Dkk-1 antibodies |
| 01/24/2012 | US8101183 Variable region sequences of IL-31 monoclonal antibodies |
| 01/24/2012 | US8101182 Methods and compositions for treating allergic diseases |
| 01/24/2012 | US8101181 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 01/24/2012 | US8101180 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |
| 01/24/2012 | US8101179 Anti-CD20 monoclonal antibody |
| 01/24/2012 | US8101178 Monoclonal antibody that specifically binds to tumor necrosis factor- alpha and comprises heavy chain complementarity determining region 1 (CDR1) for use in treating and preventing cell proliferative disorders; antitumor agents |
| 01/24/2012 | US8101177 Anti-VEGF antibodies |
| 01/24/2012 | US8101176 Compositions and methods related to TIM-3, a TH1-specific cell surface molecule |
| 01/24/2012 | US8101175 Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same |
| 01/24/2012 | US8101168 Attenuated FNR deficient enterobacteria |
| 01/24/2012 | US8101166 Methods for the treatment of IL-1β related diseases |
| 01/24/2012 | US8101165 Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors |
| 01/24/2012 | CA2501621C Immunization of non-human mammals against streptococcus equi |
| 01/24/2012 | CA2492848C Isolation and identification of t cells |
| 01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
| 01/24/2012 | CA2456055C Microoroganisms and cells for diagnosis and therapy of tumors |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2440293C Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders |
| 01/24/2012 | CA2439428C Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/24/2012 | CA2410828C Duplexed parvovirus vectors |
| 01/24/2012 | CA2387542C Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 01/24/2012 | CA2378802C Inactivated vaccine against feline calicivirus disease |
| 01/24/2012 | CA2344317C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/24/2012 | CA2274987C Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 01/24/2012 | CA2269204C Anti-erbb2 antibodies |
| 01/19/2012 | WO2012009712A2 Methods and compositions including spore-forming bacteria for increasing the health of animals |
| 01/19/2012 | WO2012009709A1 Hiv cd4 binding site based covalent immunogen compositions |
| 01/19/2012 | WO2012009640A2 B cell depletion for central nervous system injuries and methods and uses thereof |
| 01/19/2012 | WO2012009544A2 Domain insertion immunoglobulin |
| 01/19/2012 | WO2012009452A1 The role of p13k p110 delta signaling in retroviral infection and replication |
| 01/19/2012 | WO2012009447A2 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF |
| 01/19/2012 | WO2012009442A2 Anti-addl monoclonal antibody and uses thereof |
| 01/19/2012 | WO2012009289A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 01/19/2012 | WO2012009288A2 Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer |
| 01/19/2012 | WO2012009254A1 Stabilized formulations containing anti-ngf antibodies |
| 01/19/2012 | WO2012009247A1 Protective vaccine based on staphylococcus aureus protein sa2412 |
| 01/19/2012 | WO2012008594A1 Method for detecting malignant tumor cells |
| 01/19/2012 | WO2012008397A1 Anti-epha2 antibody and use thereof |
| 01/19/2012 | WO2012007981A1 Use of anti-plac1 protein antibodies as biomarkers of infertility, diagnostic kit for the detection of the immune response against plac1 and use of plac1 protein in therapeutic and contraceptive fields |
| 01/19/2012 | WO2012007847A2 Pharmaceutical compositions and methods of treatment |